Statistical considerations in DNA flow cytometry

Flow cytometry is frequently used for assessing individual cell characteristic(s) for a large number of cells. It has a variety of med- ical applications including assessing the quantity of intracellular DNA and detecting the presence of antigens such as CD4. Flow cytometric variables are evaluated for their clinical prognostic value, particularly in cancer, and are often used for clinical screening of diseased patients. The prognostic worth of these variables is questionable and is contro- versial in the medical community. This controversy is caused in part by the multiple methods of analysis and the lack of adherence to quality control standards. The analysis of flow cytometric data presents a num- ber of interesting statistical problems, particularly in deconvolution of overlapping distributions and detection of abnormal subpopulation(s) of cells. The current methods incorporate subjective procedures, may use ill-founded assumptions and yield differing results. This article summa- rizes the flow cytometry process of measurement and reviews unsolved statistical and quality control issues pertaining to the analysis of flow cytometric data. DNA histogram analysis is used to exemplify these issues.

[1]  John Rice,et al.  Deconvolution of Microfluorometric Histograms with B Splines , 1982 .

[2]  K. Bauer,et al.  Clinical flow cytometry : principles and application , 1993 .

[3]  H. Joensuu,et al.  Evidence for false aneuploid peaks in flow cytometric analysis of paraffin-embedded tissue. , 1990, Cytometry.

[4]  M. Gnant,et al.  DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study. , 1992, European journal of cancer.

[5]  J. Ensley,et al.  DNA content parameters of paraffin-embedded soft tissue sarcomas: optimization of retrieval technique and comparison to fresh tissue. , 1993, Cytometry.

[6]  A. Daver,et al.  Comparative flow DNA analysis of different cell suspensions in breast carcinoma. , 1984, Cytometry.

[7]  W. Grogan,et al.  Guide to Flow Cytometry Methods , 1990 .

[8]  J. Baak,et al.  Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast‐cancer patients with long follow‐up , 1990, International journal of cancer.

[9]  L. Peters,et al.  The predictive value of tumor-cell kinetic parameters in radiotherapy: considerations regarding data production and analysis. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  G M Clark,et al.  Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. , 1989, The New England journal of medicine.

[11]  H. Joensuu,et al.  Effect of DNA ploidy classification on prognosis in breast cancer , 1992, International journal of cancer.

[12]  M. Fernö,et al.  Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates. , 1995, Cytometry.

[13]  M. Fernö,et al.  Indicators of prognosis in node-negative breast cancer. , 1990, The New England journal of medicine.

[14]  C. Herman Cytometric DNA analysis in the management of cancer. Clinical and laboratory considerations , 1992, Cancer.

[15]  C. B. Bagwell,et al.  Effects of several commonly used fixatives on DNA and total nuclear protein analysis by flow cytometry. , 1989, American journal of clinical pathology.

[16]  W. Hiddemann,et al.  Convention on nomenclature for DNA cytometry , 1984 .

[17]  H. Joensuu,et al.  Autolysis is a potential source of false aneuploid peaks in flow cytometric DNA histograms. , 1989, Cytometry.

[18]  Bruce Bagwell,et al.  A journey through flow cytometric immunofluorescence analyses—Finding accurate and robust algorithms that estimate positive fraction distributions , 1996 .

[19]  L L Vindeløv,et al.  A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. , 1990, Cytometry.

[20]  A. Krishan,et al.  Prognostic significance of DNA aneuploidy in diffuse malignant mesothelioma. , 1995, Cytometry.

[21]  R. Silvestrini Quality control for evaluation of the S-phase fraction by flow cytometry: a multicentric study. The SICCAB Group for Quality Control of Cell Kinetic Determinations. , 1994, Cytometry.

[22]  M. Melamed,et al.  Measurement variability in DNA flow cytometry of replicate samples. , 1989, Cytometry.

[23]  L G Dressler,et al.  Controls, standards, and histogram interpretation in DNA flow cytometry. , 1990, Methods in cell biology.

[24]  N. Kenyon,et al.  Enhanced assessment of DNA/proliferative index by depletion of tumor infiltrating leukocytes prior to monoclonal antibody gated analysis of tumor cell DNA. , 1994, Cytometry.

[25]  Z. Darżynkiewicz Acid-induced denaturation of DNA in situ as a probe of chromatin structure. , 1994, Methods in cell biology.

[26]  A. Begg,et al.  The clinical status of Tpot as a predictor? Or why no tempest in the Tpot! , 1995, International journal of radiation oncology, biology, physics.

[27]  R. Braylan,et al.  Evaluation of sensitivity in DNA aneuploidy detection using a mathematical model. , 1994, Cytometry.

[28]  I. Ellis,et al.  Prognostic significance of the DNA content of human breast cancer , 1987, The British journal of surgery.

[29]  H. Joensuu,et al.  The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up. , 1989, British Journal of Cancer.

[30]  J. Jett,et al.  MATHEMATICAL ANALYSIS OF DNA DISTRIBUTIONS DERIVED FROM FLOW MICROFLUOROMETRY , 1974, The Journal of cell biology.

[31]  H. Frierson,et al.  Flow cytometric analysis of ploidy in solid neoplasms: comparison of fresh tissues with formalin-fixed paraffin-embedded specimens. , 1988, Human pathology.

[32]  I W Taylor,et al.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. , 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[33]  J. Watson,et al.  Flow Cytometry Data Analysis: Basic Concepts and Statistics , 1992 .

[34]  T. Visakorpi,et al.  Automated peak detection and cell cycle analysis of flow cytometric DNA histograms. , 1994, Cytometry.

[35]  H. Joensuu,et al.  Identification of subgroups with favorable prognosis in breast cancer. , 1992, Acta oncologica.

[36]  L. Wheeless,et al.  DNA cytometry consensus conference. , 1993, Cytometry.

[37]  R. Braylan,et al.  Flow cytometric analysis of DNA in cells obtained from deparaffinized formalin-fixed lymphoid tissues. , 1987, Cytometry.

[38]  D. Weaver,et al.  Improved flow cytometric determination of proliferative activity (S-phase fraction) from paraffin-embedded tissue. , 1990, American journal of clinical pathology.

[39]  H. Frierson The need for improvement in flow cytometric analysis of ploidy and S-phase fraction. , 1991, American journal of clinical pathology.

[40]  G Haroske,et al.  Use of nuclear image cytometry, histopathological grading and DNA cytometry to make breast cancer prognosis more objective. , 1991, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[41]  M. Bottone,et al.  Identification of resting cells by dual-parameter flow cytometry of statin expression and DNA content. , 1995, Cytometry.

[42]  W. Lewis,et al.  Prognostic significance of flow cytometric DNA analysis in node‐negative breast cancer patients , 1990, Cancer.

[43]  O. Kallioniemi,et al.  Tumour DNA ploidy as an independent prognostic factor in breast cancer. , 1987, British Journal of Cancer.

[44]  A. Givan,et al.  Flow Cytometry: First Principles , 1992 .

[45]  C. V. D. van de Velde,et al.  Prognostic significance of dna‐ploidy in a series of 690 primary breast cancer patients , 1990, International journal of cancer.

[46]  M. Fernö,et al.  Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. , 1992, Acta oncologica.

[47]  S. Fosså,et al.  Flow cytometric DNA analysis as prognostic factor in human breast carcinoma. , 1993, Pathology, research and practice.

[48]  S. Larsen,et al.  Instrument-dependent fluorochrome sensitivity in flow cytometric analyses. , 1995, Cytometry.

[49]  D. Marquardt An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .

[50]  S. Swerdlow,et al.  Flow-cytometric DNA analysis of hematopoietic and lymphoid proliferations: a comparison of fresh, formalin-fixed and B5-fixed tissues. , 1990, Human pathology.

[51]  R. Camplejohn,et al.  Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  H. Joensuu,et al.  Comparison of fresh, ethanol-preserved, and paraffin-embedded samples in DNA flow cytometry. , 1989, Cytometry.

[53]  Howard M. Shapiro,et al.  Practical Flow Cytometry , 1985 .

[54]  J. Fried Method for the quantitative evaluation of data from flow microfluorometry. , 1976, Computers and biomedical research, an international journal.

[55]  Z. Darżynkiewicz,et al.  Simultaneous analysis of cell cycle kinetics at two different DNA ploidy levels based on DNA content and cyclin B measurements. , 1993, Cancer research.

[56]  C. Cox,et al.  Guidelines for the implementation of clinical DNA cytometry , 2004, Breast Cancer Research and Treatment.

[57]  W. Farrar,et al.  Is DNA ploidy an independent prognostic indicator in infiltrative node‐negative breast adenocarcinoma? , 1990, Cancer.

[58]  J. Larsen,et al.  Flow cytometric discrimination of mitotic cells: resolution of M, as well as G1, S, and G2 phase nuclei with mithramycin, propidium iodide, and ethidium bromide after fixation with formaldehyde. , 1986, Cytometry.

[59]  C Nicolini,et al.  A comparison of mathematical methods for the analysis of DNA histograms obtained by flow cytometry , 1982, Cell and tissue kinetics.